17-7224487-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 3P and 1B. PM2PP5BP4
The NM_000018.4(ACADVL):āc.1613G>Cā(p.Arg538Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000889 in 1,461,510 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000018.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000798 AC: 2AN: 250696Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135634
GnomAD4 exome AF: 0.00000889 AC: 13AN: 1461510Hom.: 0 Cov.: 42 AF XY: 0.00000825 AC XY: 6AN XY: 727022
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Very long chain acyl-CoA dehydrogenase deficiency Pathogenic:2Uncertain:2
- -
The ACADVL c.1613G>C; p.Arg538Pro variant (rs201350598) is reported in the literature in at least one individual affected with very long-chain acyl-coenzyme A dehydrogenase (VLCAD) deficiency (Laforet 2009). This variant is also reported in ClinVar (Variation ID: 235256), and is only observed on two alleles in the Genome Aggregation Database, indicating it is not a common polymorphism. The arginine at codon 538 is weakly conserved, and computational analyses are uncertain whether this variant is neutral or deleterious (REVEL: 0.540). Due to the lack of clinical and functional data, the significance of the p.Arg538Pro variant is uncertain at this time. References: Laforet P et al. Diagnostic assessment and long-term follow-up of 13 patients with Very Long-Chain Acyl-Coenzyme A dehydrogenase (VLCAD) deficiency. Neuromuscul Disord. 2009 May;19(5):324-9. PMID: 19327992. -
This sequence change replaces arginine, which is basic and polar, with proline, which is neutral and non-polar, at codon 538 of the ACADVL protein (p.Arg538Pro). This variant is present in population databases (rs201350598, gnomAD 0.0009%). This missense change has been observed in individual(s) with very long-chain acyl-CoA dehydrogenase deficiency (PMID: 19327992). ClinVar contains an entry for this variant (Variation ID: 235256). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt ACADVL protein function with a positive predictive value of 95%. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
The NM_000018.3:c.1613G>C (NP_000009.1:p.Arg538Pro) [GRCH38: NC_000017.11:g.7224487G>C] variant in ACADVL gene is interpretated to be Pathogenic based on ACMG guidelines (PMID: 25741868). This variant has been reported in PMID: 19327992. This variant meets the following evidence codes reported in the ACMG guidelines: PS1, PS3 -
not provided Uncertain:2
- -
Not observed at a significant frequency in large population cohorts (Lek et al., 2016); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 19327992, 27209629) -
not specified Uncertain:1
Variant summary: ACADVL c.1613G>C (p.Arg538Pro) results in a non-conservative amino acid change located in the ACAD9/ACADV-like, C-terminal domain (IPR049448) of the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 8e-06 in 250696 control chromosomes. c.1613G>C has been reported in the literature in compound heterozygous individuals affected with Very Long Chain Acyl-CoA Dehydrogenase Deficiency (Laforet_2009, Pena_2016). These data indicate that the variant may be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 19327992, 27209629). ClinVar contains an entry for this variant (Variation ID: 235256). Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at